Clinical Trials Insight: 700027407
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2008
At a glance
- Drugs Plovamer (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 18 Sep 2008 Further data was presented at the World Congress on Treatment and Research in Multiple Sclerosis.
- 09 Jun 2008 Results presented at the 17th European Neurological Society and the Federation of Clinical Immunology Societies in June 2008.
- 18 Mar 2008 Status changed from in progress to completed according to a Peptimmune media release.